FINWIRES · TerminalLIVE
FINWIRES

TenNor Therapeutics Launches Up to HK$627 Million Hong Kong IPO

By

TenNor Therapeutics (HKG:6872) launched its Hong Kong initial public offering on Thursday, seeking to raise about HK$626.8 million from the deal.

The China-based near-commercial stage biotechnology company is offering 8.3 million shares at HK$75.70 each, according to a Hong Kong bourse filing.

The offering comprises 828,100 shares for Hong Kong investors and 7.5 million shares for international investors, subject to reallocation, the offer size adjustment option, and the overallotment option.

Allocation results are due by May 21, ahead of the company's planned trading debut on May 22.

Net proceeds will be used mainly to fund the research, development, regulatory filings, and commercialization of core products rifasutenizol and rifaquizinone injection.

The funds will also be used to support clinical development of TNP-2092, advance other pipeline candidates, construct an in-house manufacturing facility in Guangdong, and for working capital and general corporate purposes.

CITIC Securities (Hong Kong) and ABCI Capital are acting as joint sponsors.

CLSA and ABCI Capital are serving as sponsor-overall coordinators, overall coordinators, and joint global coordinators, while also acting as joint bookrunners alongside China Renaissance Securities (Hong Kong).

CLSA, ABCI Securities Company, China Renaissance Securities (Hong Kong), Futu Securities International (Hong Kong), and Tiger Brokers (HK) Global are acting as joint lead managers.

Related Articles

Asia

WiseTech Global Share Price Expected to Face Pressure After Largest Customer Signals Move Away from WiseTech Global's CargoWise, Jefferies Says

WiseTech Global's (ASX:WTC) share price is expected to come under pressure after DSV, one of its largest customers, decided to consolidate its air and sea transport management systems, transitioning away from CargoWise, Jefferies said in a Tuesday note.DSV confirmed its strategic shift from CargoWise to Schenker's Tango. However, this could be a multi-year journey, and DSV continues to migrate Schenker users into CargoWise.DSV spends about $150 million per year on CargoWise, representing around 9% of WiseTech's revenue and around 10% of earnings before interest, taxes, depreciation, and amortization (EBITDA) in fiscal 2027.The investment firm retained WiseTech Global's buy rating and AU$72 per share price target.

ASX:WTC
Asia

Ganfeng Lithium Cancels Stock Options on Missed Target; Shares Fall 4%

Ganfeng Lithium (SHE:002460, HKG:1772) canceled 551,250 stock options after failing to meet company performance goals for the fourth exercise period of its 2022 incentive plan.The cancellation was confirmed May 12 via the Shenzhen depository, according to a Wednesday filing with the Shenzhen bourse.The options were tied to fiscal years 2022 to 2025.Shares of the lithium miner fell 4% in recent trade on the Hong Kong bourse.

HKG:1772SHE:002460
Asia

South Korea to Raise Safety Inspections on Overseas Direct Purchases

South Korea plans to increase safety inspections on its overseas direct purchase on concerns about the influx of hazardous products amid an increase in cross-border e-commerce and online sales, the Office for Government Policy Coordination said in a Wednesday release.Safety inspections will be raised to over 2,000 by 2028 from about 1,000 cases in 2025.The government plans to boost inspection by applying data and AI across the entire product safety lifecycle and shifting toward preventive regulation, the release said.The initiative outlines four core strategies and 16 key tasks that are aimed at improving public confidence, it said.

^KOSDAQKOSPI